CDKN2B-AS1 rs2184061: Longevity and Genetic Variation
The rs2184061 variant is a genetic marker located within the CDKN2B-AS1 gene region on chromosome 9. It has been identified in large-scale meta-analyses as being associated with parental lifespan and extreme human longevity.
What each genotype means
Typical longevity association
You carry two copies of the C allele at this locus within the CDKN2B-AS1 region. In genome-wide association studies evaluating extreme human longevity and cellular aging markers, this genotype is considered the baseline profile and is not associated with the increased odds of extreme survival linked to the minor allele. This represents a typical population lifespan association rather than an individual health prediction.
Carried by approximately 31% to 35% of individuals of European ancestry; it is the most common genotype in several non-European populations.
Moderately increased longevity odds
You carry one copy of the T allele associated with human healthspan and longevity. Large meta-analyses of long-lived individuals suggest that carrying one T allele confers a modest statistical association with reaching extreme ages. However, lifespan is shaped by complex gene-environment interactions, lifestyle, and many other genetic factors, so this does not guarantee individual longevity outcomes.
Carried by roughly 48% to 50% of individuals of European ancestry, representing the most frequent genotype in this population.
Increased longevity odds
You carry two copies of the T allele in the CDKN2B-AS1 locus, which influences cellular senescence pathways involving p15 and p16. In observational genetic studies of centenarians and parental lifespan, individuals with this genotype show the strongest statistical association with extreme human survival. These statistical associations reflect population-level trends rather than a clinical certainty for any single person.
Carried by approximately 18% to 20% of people of European ancestry, and occurs at lower rates in East Asian and African populations.
Understanding the rs2184061 Variant
The rs2184061 variant is a single nucleotide polymorphism (SNP) situated within the CDKN2B-AS1 gene, also known as ANRIL. This gene is located in a critical region on chromosome 9p21.3, which is well-known in genomics for its involvement in various age-related conditions. In the context of genetic research, rs2184061 serves as a marker that researchers track to understand how specific DNA sequences might influence the biological processes that determine how long an individual lives. It is important to note that this variant does not act in isolation; rather, it sits within a complex genomic neighborhood that regulates the expression of nearby genes involved in cell cycle control and senescence. Scientists use this SNP to investigate the polygenic nature of human survival, looking for patterns that distinguish individuals who reach extreme old age from the general population.
The Role of CDKN2B-AS1
The CDKN2B-AS1 gene produces a long non-coding RNA (lncRNA) molecule. Unlike protein-coding genes that provide instructions for building cellular machinery, lncRNAs like ANRIL act as regulators that help control the activity of other genes. Specifically, CDKN2B-AS1 interacts with protein complexes that modify the structure of chromatin, effectively turning the expression of nearby genes—such as CDKN2A and CDKN2B—on or off. These target genes are crucial because they encode proteins that act as 'brakes' on the cell cycle, preventing cells from dividing uncontrollably. By regulating these brakes, CDKN2B-AS1 plays a fundamental role in cellular senescence, the process by which cells stop dividing as they age. Because senescence is a hallmark of biological aging, variations in this regulatory gene are hypothesized to influence how tissues maintain their function over a human lifespan.
Research and Longevity Associations
Research into rs2184061 has primarily focused on its statistical association with longevity. Large-scale genome-wide association studies (GWAS) and meta-analyses have observed that this variant, along with others in the 9p21 region, correlates with parental lifespan and the ability to reach extreme ages. Some studies have linked this locus to the regulation of specific serum proteins, such as GDF15, which are known biomarkers of aging. While these associations are statistically significant in large cohorts, the evidence strength is considered moderate. This is because longevity is a highly complex trait influenced by thousands of genetic variants, environmental factors, and lifestyle choices. While rs2184061 is a consistent signal in longevity research, it is not a 'longevity gene' that guarantees a specific outcome. Instead, it represents one small piece of a much larger, intricate puzzle regarding how our biology manages the passage of time.
Interpreting Genetic Information
It is essential to understand that genetic associations with longevity are probabilistic, not deterministic. Having a specific genotype at the rs2184061 locus does not provide a medical diagnosis or a prediction of an individual's lifespan. The findings discussed here are based on population-level data, which describe trends across thousands of people rather than the health trajectory of a single person. Readers should be cautious of any claims that suggest a single SNP can determine health outcomes or life expectancy. Genetic information is best viewed as a tool for scientific inquiry into biological mechanisms rather than a guide for personal health management. If you have questions about your health, family history, or how to optimize your well-being as you age, the most reliable approach is to consult with a qualified healthcare professional who can provide personalized guidance based on your complete clinical picture.
How common is this variant?
The minor allele frequency for rs2184061 is approximately 0.44 in European populations according to gnomAD data, indicating that both alleles are quite common.
Frequently asked questions
Does rs2184061 determine how long I will live?
No. Longevity is a complex trait influenced by a vast array of genetic, environmental, and lifestyle factors. A single SNP like rs2184061 provides only a tiny fraction of information and cannot predict an individual's lifespan.
Is CDKN2B-AS1 associated with other diseases?
Yes. The 9p21 region where this gene is located has been associated in various studies with cardiovascular disease, type 2 diabetes, and certain cancers. These associations are separate from its role in longevity research.
What is a long non-coding RNA?
A long non-coding RNA is a type of RNA molecule that does not code for proteins. Instead, it functions as a regulator that helps control gene expression and cellular processes.
Should I get tested for this variant?
There is no clinical utility in testing for this variant for the purpose of predicting longevity. Genetic testing for such markers is generally reserved for research settings rather than routine medical care.
Sources & further reading
Educational information only, last refreshed 10/18/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2184061?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CDKN2B-AS1
This variant in the CDKN2B-AS1 long noncoding RNA gene is associated with extreme longevity in genome-wide association studies.
A non-coding variant in the CDKN2B-AS1 locus associated with human longevity and survival beyond 90 years of age.
Non-coding RNA locus SNP associated with endometriosis development through altered regulation of cell cycle progression and local tissue remodeling.
This variant is a well-established risk locus for coronary artery disease and related cardiovascular conditions.
Located in the non-coding CDKN2B-AS1 locus, this variant confers significant risk for normal-tension and primary open-angle glaucoma.
Chromosome 9p21 non-coding regulatory variant conferring increased predisposition to coronary artery disease, myocardial infarction, and intracranial aneurysm.